Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107495223 | 10749522 | 3 | F | 201410 | 20160816 | 20150129 | 20160823 | EXP | JP-PFIZER INC-2015003702 | PFIZER | 8.00 | YR | M | Y | 34.00000 | KG | 20160823 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107495223 | 10749522 | 1 | PS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | UNK | 220 | MG | Y | 20280 | POWDER FOR SOLUTION FOR INJECTION | ||||||
| 107495223 | 10749522 | 2 | SS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 1.05 MG, CYCLIC (6X/WEEK) | 220 | MG | Y | 20280 | 1.05 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||
| 107495223 | 10749522 | 3 | SS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 1.75 MG, 1X/DAY | 220 | MG | Y | 20280 | 1.75 | MG | POWDER FOR SOLUTION FOR INJECTION | QD | |||
| 107495223 | 10749522 | 4 | SS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 1.5 MG, 1X/DAY | 220 | MG | Y | 20280 | 1.5 | MG | POWDER FOR SOLUTION FOR INJECTION | QD | |||
| 107495223 | 10749522 | 5 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 0.4 G, 2X/DAY | 0 | .4 | G | GRANULES | BID | ||||||
| 107495223 | 10749522 | 6 | C | STRATTERA | ATOMOXETINE HYDROCHLORIDE | 1 | Oral | UNK | 1350 | ML | 0 | ||||||||
| 107495223 | 10749522 | 7 | C | STRATTERA | ATOMOXETINE HYDROCHLORIDE | 1 | Oral | 9 ML, 2X/DAY | 1350 | ML | 0 | 9 | ML | BID | |||||
| 107495223 | 10749522 | 8 | C | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 0.1 G, 2X/DAY | 0 | .1 | G | GRANULES | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107495223 | 10749522 | 1 | Prader-Willi syndrome |
| 107495223 | 10749522 | 5 | Oppositional defiant disorder |
| 107495223 | 10749522 | 6 | Oppositional defiant disorder |
| 107495223 | 10749522 | 8 | Oppositional defiant disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107495223 | 10749522 | HO |
| 107495223 | 10749522 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107495223 | 10749522 | Diabetes mellitus | |
| 107495223 | 10749522 | Diabetic ketoacidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107495223 | 10749522 | 2 | 20120419 | 201212 | 0 | |
| 107495223 | 10749522 | 3 | 20140704 | 20141106 | 0 | |
| 107495223 | 10749522 | 4 | 20141107 | 20150104 | 0 | |
| 107495223 | 10749522 | 5 | 20131022 | 0 | ||
| 107495223 | 10749522 | 6 | 20140905 | 0 | ||
| 107495223 | 10749522 | 7 | 20140927 | 20141210 | 0 | |
| 107495223 | 10749522 | 8 | 20141210 | 0 |